Johnson & Johnson enters definitive agreement to acquire Ollin Biosciences
JNJ
Statements (8)
- Neutral
Johnson & Johnson agreed to acquire Ollin Biosciences for $2.2 billion upfront.
- Bullish
Johnson & Johnson announced a deal to acquire Ollin Biosciences for up to $3.3 billion
- Bullish
Johnson & Johnson announced it will acquire Ollin Biosciences Inc. for up to $3.3 billion.
- Neutral
Ollin Biosciences is being acquired by Johnson & Johnson for $2.2 billion upfront.
- Bullish
Johnson & Johnson entered into a definitive agreement to acquire Ollin Biosciences for $2.2 billion upfront.
- Bullish
Johnson & Johnson is close to acquiring Ollin Biosciences in a deal valued at up to $3.4 billion.
- Neutral
Johnson & Johnson is considering acquiring Ollin Biosciences for $3.4 billion
- Neutral
Johnson & Johnson is looking to acquire Ollin Biosciences for up to $3.4 billion